Send E-mail
  • Cell Biotech earns patent for inflammatory bowel disease treatment
    Cell Biotech earns patent for inflammatory bowel disease treatment
    Cell Biotech (049960) said on Sept. 5 that it has acquired a patent for a composition that prevents and treats inflammatory bowel disease, based on four kinds of probiotics lactic acid bacteria that the company owns. By Park Yuna (yunapark@heraldcorp.com)
From
Send to
Close Send

Cell Biotech earns patent for inflammatory bowel disease treatment

Sept. 5, 2016 - 10:35 By 박윤아
[DISCLOSURE] Cell Biotech (049960) said on Sept. 5 that it has acquired a patent for a composition that prevents and treats inflammatory bowel disease, based on four kinds of probiotics lactic acid bacteria that the company owns.

By Park Yuna (yunapark@heraldcorp.com)
Most Popular